Argitalpenak (90) MIGUEL DÍAZ HERNÁNDEZ argitalpenak Ikerketa datu erreferentziatuak ikusi.

2024

  1. Blockade of brain alkaline phosphatase efficiently reduces amyloid-β plaque burden and associated cognitive impairment

    Alzheimer's research & therapy, Vol. 16, Núm. 1, pp. 233

  2. Diadenosine pentaphosphate regulates dendrite growth and number in cultured hippocampal neurons

    Purinergic Signalling, Vol. 20, Núm. 2, pp. 115-125

  3. Editorial: Protein post-translational modifications in the nervous system: from development to disease and ageing

    Frontiers in Molecular Neuroscience

2023

  1. P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 15, Núm. 1

  2. TNAP and P2X7R: New Plasma Biomarkers for Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 13

2022

  1. Editorial: Protein Degradation, Aggregation, Membrane Trafficking and Exosomes in Neuronal Health and Disease

    Frontiers in Molecular Neuroscience

  2. P2X7 receptor blockade reduces tau induced toxicity, therapeutic implications in tauopathies

    Progress in Neurobiology, Vol. 208

  3. Purinergic Signalling and Inflammation-Related Diseases

    Cells

  4. Studying the Role of P2X7 Receptor in Axonal Growth Using In Utero Electroporation Technique

    Methods in Molecular Biology (Humana Press Inc.), pp. 355-366

  5. TNAP upregulation is a critical factor in Tauopathies and its blockade ameliorates neurotoxicity and increases life-expectancy

    Neurobiology of Disease, Vol. 165

2021

  1. Editorial: P2X7 as Common Therapeutic Target in Brain Diseases

    Frontiers in Molecular Neuroscience

2020

  1. ATP measurement in cerebrospinal fluid using a microplate reader

    Methods in Molecular Biology (Humana Press Inc.), pp. 233-241

2019

  1. Amyloid peptide induced neuroinflammation increases the P2X7 receptor expression in microglial cells, impacting on its functionality

    Frontiers in Cellular Neuroscience, Vol. 13

  2. Nucleotides regulate the common molecular mechanisms that underlie neurodegenerative diseases; Therapeutic implications

    Brain Research Bulletin, Vol. 151, pp. 84-91

  3. Peripheral nervous system effects in the PS19 tau transgenic mouse model of tauopathy

    Neuroscience Letters, Vol. 698, pp. 204-208

2018

  1. Haploinsufficient TNAP mice display decreased extracellular ATP levels and expression of Pannexin-1 channels

    Frontiers in Pharmacology, Vol. 9, Núm. MAR

  2. MicroRNA-22 controls aberrant neurogenesis and changes in neuronal morphology after status epilepticus

    Frontiers in Molecular Neuroscience, Vol. 11

  3. The neurotoxic role of extracellular tau protein

    International Journal of Molecular Sciences, Vol. 19, Núm. 4

  4. The regulation of proteostasis in glial cells by nucleotide receptors is key in acute neuroinflammation

    FASEB Journal, Vol. 32, Núm. 6, pp. 3020-3032

2017

  1. Neuronal P2X7 receptor: Involvement in neuronal physiology and

    Journal of Neuroscience, Vol. 37, Núm. 30, pp. 7063-7072